Is autonomous practice safe for patients?

Is autonomous practice safe for patients?

As the Oklahoma Legislature clears the way for autonomous practice by nurse practitioners, it’s time for a broader conversation regarding the scope and duration of training and certification needed to independently provide care to patients of all types, says Patrick Aguilar, MD, a business of health expert at WashU Olin Business School.
Class Acts: M.J. Brown

Class Acts: M.J. Brown

From Eagle Scout to Ervin Scholar, M.J. Brown leads with commitment to service and values. Now the soon-to-be Olin Business School graduate prepares to follow his dreams across the country where he’ll work as an associate product marketing manager at Google in San Francisco.
What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

What Walgreens’ $10 billion private equity deal means for consumers, pharmacy industry

After years of financial turmoil, Walgreens recently announced that it has reached a $10 billion buyout deal with private-equity firm Sycamore — a move that likely will have wide-ranging consequences for how consumers access health care and health-care products, according to Olin Business School experts Patrick Aguilar and Peter Boumgarden.
Older Stories